HIV Drugs Global Market Report 2021: COVID-19 Implications And Growth To 2030 By The Business Research Company
The HIV Drugs Market Is Segmented By Type Into Nucleoside Reverse Transcriptase Inhibitors, Non-Nucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors; By Application Into Hospital Pharmacy, Retail Pharmacy; By Route Of Admiration Into Oral And Parenteral.
LONDON, Feb. 18, 2021 (GLOBE NEWSWIRE) -- As per The Business Research Company’s research on the global HIV drugs market, the global HIV drugs market is expected to grow from $30 billion in 2020 to $36 billion by 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth of the HIV drugs market is driven by various factors including the COVID-19 outbreak, developments in drug discovery procedures, and government initiatives.
The demand for HIV drugs is anticipated to grow at a rapid pace due to the COVID-19 outbreak. Companies are trying to repurpose existing drugs in the fight against the novel coronavirus. The use of certain existing HIV drugs for COVID-19 treatment is contributing to the growth of the HIV drug market. For instance, several countries are evaluating and using antiretroviral drugs (such as lopinavir boosted with ritonavir (LPV/r)), for treating coronavirus infections. This scenario is projected to drive the HIV drug market in the forecast period.
The HIV drug market is also expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics, and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies.
Request For A Sample Of The Global HIV Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2834&type=smp
The Business Research Company’s report titled HIV Drugs Global Market Report 2021: COVID 19 Implications And Growth To 2030 covers HIV drugs manufacturers, HIV drugs market size, and HIV drugs market forecasts. The report also covers the global HIV drugs market and its major players.
The HIV drugs market is concentrated, with a small number of large players in the market. The top eight competitors in the market made up to 92.9% of the total market in 2020. Major players in the market include Gilead Sciences Inc., GlaxoSmithKline, Johnson & Johnson, Merck & Co. Inc., Boehringer Ingelheim GmbH.
HIV Drugs Global Market Report 2021: COVID 19 Implications And Growth To 2030 is one of a series of new reports from The Business Research Company that provide HIV drugs market overviews, analyze and HIV drugs forecast market size and growth for the whole HIV drugs market, HIV drugs market segments and geographies, HIV drugs market trends, HIV drugs market drivers, HIV drugs market restraints, leading competitors’ revenues, profiles and market shares in over 1,000 industry reports, covering over 2,500 market segments and 60 geographies.
The report also gives in-depth analysis of the impact of COVID-19 on the market. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. A highly experienced and expert team of analysts and modelers provides market analysis and forecasts. The reports identify top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here Is A List Of Similar Reports By The Business Research Company:
Pharmaceuticals Market - Opportunities And Strategies – Global Forecast To 2030
Oral Biologics And Biosimilars Market - Opportunities And Strategies - Global Forecast To 2030
Global Biologics Market - Opportunities And Strategies – Global Forecast To 2023
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
The World’s Most Comprehensive Database
The Business Research Company’s flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
Contact Information The Business Research Company Europe: +44 207 1930 708 Asia: +91 8897263534 Americas: +1 315 623 0293 Email: info@tbrc.info Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company Follow us on Twitter: https://twitter.com/tbrc_info
